These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20462721)

  • 21. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural analysis of photo-degradation in thiazole-containing compounds by LC-MS/MS and NMR.
    Wu L; Hong TY; Vogt FG
    J Pharm Biomed Anal; 2007 Jul; 44(3):763-72. PubMed ID: 17442527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS.
    Huynh NH; Tyrefors N; Ekman L; Johansson M
    J Pharm Biomed Anal; 2005 Apr; 37(5):1095-100. PubMed ID: 15862690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
    J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification, synthesis and quantification of process-related impurities in auraptene.
    Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
    J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of process-related impurities and degradation products in larotaxel.
    Che X; Shen L; Xu H; Liu K
    J Pharm Biomed Anal; 2011 Jul; 55(5):1190-6. PubMed ID: 21530132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forced degradation studies of elagolix sodium with the implementation of high resolution LC-UV-PDA-MS
    Zhong X; Lv Q; Yong Q; Hu W; Li D; Ji S; Zhan L; Chen W; Li M; Lin J; Sun C
    J Pharm Biomed Anal; 2023 Feb; 224():115198. PubMed ID: 36495708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of imatinib mesylate degradation products obtained under stress conditions.
    Szczepek WJ; Kosmacińska B; Bielejewska A; Łuniewski W; Skarzyński M; Rozmarynowska D
    J Pharm Biomed Anal; 2007 Apr; 43(5):1682-91. PubMed ID: 17307328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method.
    Raman NV; Harikrishna KA; Prasad AV; Reddy KR; Ramakrishna K
    J Pharm Biomed Anal; 2010 Mar; 51(4):994-7. PubMed ID: 20005658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.
    Bianchini RM; Castellano PM; Kaufman TS
    J Pharm Biomed Anal; 2008 Dec; 48(4):1151-60. PubMed ID: 18922659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of volatile degradants in formulations containing sesame oil using SPME/GC/MS.
    Chen W; Zhou P; Wong-Moon KC; Cauchon NS
    J Pharm Biomed Anal; 2007 Jun; 44(2):450-5. PubMed ID: 17412547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of high resolution LC-MSn analysis in conjunction with mechanism-based stress studies: identification of asarinin, an impurity from sesame oil in an animal health product.
    Wang X; Peng Y; Li M; Rustum AM
    J Pharm Biomed Anal; 2009 Dec; 50(5):1015-21. PubMed ID: 19631486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
    Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
    J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC determination of glimepiride and its related impurities.
    Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
    J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.